NCT03322345View on ClinicalTrials.gov

Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

Enrolling by invitationOBSERVATIONAL

Enrollment

24

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions

DopamineProtein-Losing EnteropathiesLymphatic SystemLymphCatecholamineSingle-ventricleCongenital Heart Disease

Trial Locations (1)

48109

University of Michigan Health System, Ann Arbor

All Listed Sponsors

lead

University of Michigan

OTHER